Changes in Markers of Inflammation and Endothelial Damage at Noncardiac Surgeries in Elderly Patients
Introduction. An increase in the number of elderly patients is a serious problem for both the surgery and anaesthesiology. The most serious complication of perioperative period in the elderly is the development of myocardial infarction. Endothelial dysfunction plays an important role in the development of ischemic heart disease. The synthesis of endothelin-1 determines endothelial dysfunction and is far ahead of the appearance of clinical signs of disease. Another important marker of complications is interleukin-6 — patients have an activation of the inflammatory process. But there is a little information on the analysis of inflammatory markers in patients with ischemic heart disease in terms of perioperative complications in noncardiac surgery. Objective of the study was to examine and to evaluate the functional state of the endothelium and dynamics of proinflammatory interleukin-6 level in elderly patients with concomitant cardiovascular pathology in pre- and postoperative period of noncardiac surgical interventions. Materials and methods. The study involved 55 patients aged 60 to 82 years, who were admitted to the hospital for elective abdominal surgery. Laboratory studies were performed with the definition of endothelin-1 and interleukin-6 level in EDTA-plasma using enzyme immunoassay. Results. It is proved that elderly patients have increased levels of endothelin-1 and proinflammatory interleukin-6 in the blood plasma, indicating the presence of endothelial dysfunction and activation of proinflammatory system. In the early postoperative period, vascular endothelium responds to operational trauma by a release of vasoconstrictor and proinflammatory markers. By the fifth postoperative day, the signs of endothelial dysfunction and inflammation in the elderly are reduced, but not disappeared completely. Conclusion. Increase in the levels of endothelin-1 and interleukin-6 established in the study confirms the information about their role as markers of endothelial dysfunction.
Arora V., Velanovich V., Alarcon W. Preoperative assessment of cardiac risk and perioperative cardiac management in noncardiac surgery // International Journal of Surgery. — 2011. — Vol. 9, Issue 1. — P. 23-28.
Bill K.М. Anaesthesia for patients with cardiac disease undergoing non-cardiac surgery // Anaesthesia and Intensive Care Medicine. — 2012. — Vol. 13, Issue 10. — P. 519-523. DOI: http://dx.doi.org/10.1016/j.mpaic.2012.08.010.
Cannesson M., Earing M.G., Collange V., Kersten J.R. Anesthesia for noncardiac surgery in adults with congenital heart disease // Anesthesiology. — 2009. — Vol. 111, Issue 2. — P. 432-440.
Fleisher L.A., Fleischmann K.E., Auerbach A.D. et al. ACC/AHA Guideline on Perioperative Cardiovascular Evaluation and Management of Patients Undergoing Noncardiac Surgery: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines // J. Am. Coll. Cardiol. — 2014. — Vol. 64, Issue 22. — P. 2373-2405.
Sarwar N., Butterworth A.S., Freitag D.F., Gregson J., Willeit P., Gorman D.N. et al. Interleukin‑6 receptor pathways in coronary heart disease: a collaborative meta-analysis of 82 studies // Lancet. — 2012. — Vol. 379, Issue 9822. — Р. 1205-1213.
Shinohara T., Takahashi N., Okada N., Ayabe R., Kondo H. et al. Interleukin‑6 as an Independent Predictor of Future Cardiovascular Events in Patients with Type‑2 Diabetes without Structural Heart Disease // J. Clin. Exp. Cardiolog. — 2012. — Vol. 3, Issue 9. — Р. 5.
Tamariz L., Hare J.M. Inflammatory cytokines in heart failure: roles in aetiology and utility as biomarkers // Eur. Heart J. — 2010. — Vol. 31, Issue 7. — Р. 768-770.
Tomas M.J., Baluyot P.M., Santos A.L.D., Faustino J., Licudine E. et al. Interleukin 6 as a Biomarker of Ischemic Heart Disease // International Journal of Scientific and Research Publications. — 2015. — Vol. 5, Issue 7. — Р. 1-4.
Jankowich M.D., Wu W.Ch., Choudhary G. Association of Elevated Plasma Endothelin‑1 Levels With Pulmonary Hypertension, Mortality, and Heart Failure in African American Individuals: The Jackson Heart Study // JAMA Cardiol. Published online 2016. Available at: http://cardiology.jamanetwork.com/article.aspx?articleid=2527091.Doi:10.1001/jamacardio.2016.0962.
Kitada K., Ohkita M., Matsumura Y. Pathological Importance of the Endothelin‑1/ETB Receptor System on Vascular Diseases // Cardiology Research and Practice. — 2012. — Vol. 2012. — Р. 7.
Latus H., Karanatsios G., Basan U., Salser K., Müller S. Clinical and prognostic value of endothelin‑1 and big endothelin‑1 expression in children with pulmonary hypertension // Heart. — 2016. — Vol. 102. — P. 1052-1058.
Copyright (c) 2016 EMERGENCY MEDICINE
This work is licensed under a Creative Commons Attribution 4.0 International License.
© Publishing House Zaslavsky, 1997-2020